India's cardiac and anti-diabetes drugs market has surged over threefold in the past decade, reaching ₹30,000 crore and ₹17,000 crore respectively. Innovative medicines and loss of patents have driven growth, with several brands now contributing significantly to market turnover.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VGmJgX1
via IFTTT
No comments:
Post a Comment